The levodopa dose-sparing capacity of pergolide compared with that of bromocriptine in an open-label, crossover study
- 20 January 1996
- journal article
- Published by Wiley in European Journal of Neurology
- Vol. 3 (1) , 44-49
- https://doi.org/10.1111/j.1468-1331.1996.tb00188.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A “combined” levodopa test as a useful method for evaluating the efficacy of dopamine agonists: Application to pergolide and bromocriptineMovement Disorders, 1995
- Treatment of Parkinson's Disease With Pergolide: A Double-Blind StudyMayo Clinic Proceedings, 1988
- Long-Term Use of Dopamine Agonists in Parkinsonʼs DiseaseClinical Neuropharmacology, 1985
- Double‐blind trial of pergolide for Parkinson's diseaseNeurology, 1985
- Oxidative Stress in the Nervous SystemPublished by Elsevier ,1985
- Long‐term treatment with pergolideNeurology, 1984
- Comparison of pergolide and bromocriptine therapy in parkinsonismNeurology, 1983
- The use of pergolide, a potent dopamine agonist, in parkinson's diseaseClinical Pharmacology & Therapeutics, 1982
- Effect of ergot drugs on central catecholamine neurons: Evidence for a stimulation of central dopamine neuronsJournal of Pharmacy and Pharmacology, 1973
- ParkinsonismNeurology, 1967